1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(cycloheptylmethyl)-4-piperidinyl]propan-1-one fumarate salt – Pharmaceutical composition and associated uses
FR3166146A1Pending Publication Date: 2026-03-13UNIV CAEN
2 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- FR · FR
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2026-03-13
Abstract
1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(cycloheptylmethyl)-4-piperidinyl]propan-1-one fumarate salt – Pharmaceutical composition and associated use. The present invention relates to a compound selected from the fumarate salt of 1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(cycloheptylmethyl)-4-piperidinyl]propan-1-one, and the hydrates of this salt, said compound being in particular in the crystalline solid state. The present invention also relates to a pharmaceutical composition, comprising as a pharmaceutically active ingredient the compound of the invention, as well as the compound of the invention for its use as a medicament and in particular for its use in the treatment of a neurodegenerative disease selected in particular from Alzheimer's disease and Parkinson's disease. Figure for the abstract: None
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Acetylcholinesterase inhibitor compounds and 5ht4 serotonergic receptor agonists, with promnesia effect, methods for the preparation thereof and pharmaceutical compositions containing same
WO2014195593A2
Donecopride as neuroprotective agent in the treatment of neurodegenerative diseases
WO2020065028A1